Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan
· Delayed Price · Currency is JOD 1.550
0.00 (0.00%)
At close: Feb 25, 2026
ASE:PHIL Revenue
Philadelphia Pharmaceuticals Company had revenue of 2.08M JOD in the quarter ending September 30, 2025, a decrease of -3.47%. This brings the company's revenue in the last twelve months to 9.11M, up 1.83% year-over-year. In the year 2024, Philadelphia Pharmaceuticals Company had annual revenue of 8.76M with 4.25% growth.
Revenue (ttm)
9.11M
Revenue Growth
+1.83%
P/S Ratio
1.28
Revenue / Employee
70.64K
Employees
129
Market Cap
11.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.76M | 357.51K | 4.25% |
| Dec 31, 2023 | 8.40M | -10.46K | -0.12% |
| Dec 31, 2022 | 8.42M | 1.81M | 27.48% |
| Dec 31, 2021 | 6.60M | -1.05M | -13.77% |
| Dec 31, 2020 | 7.66M | -1.46M | -16.01% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Arabia Insurance Company - Jordan | 23.14M |
| United Financial Investments Company | 1.95M |
| Future Arab Investment Company | 24.81M |
| Industrial Commercial & Agricultural | 29.55M |
| Nutridar Company | 16.07M |
| Universal Modern Industries Co. For Edible Oil | 9.76M |
| Jordanian Expatriates Investment Holding Company | 1.64M |
| Delta Insurance Company | 26.30M |